Consolidated Statement of Results of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended				9 Months Ended
	Sep. 30, 2022		Sep. 30, 2021		Sep. 30, 2022		Sep. 30, 2021
Sales and revenues:
Sales and revenues	$ 14,994		$ 12,397		$ 42,830		$ 37,173
Operating costs:
Cost of goods sold	10,202		8,617		29,736		25,510
Selling, general and administrative expenses	1,401		1,340		4,172		3,943
Research and development expenses	476		427		1,413		1,247
Other operating (income) expenses	339		238		908		854
Total operating costs	12,569		10,733		36,606		31,906
Operating profit	2,425		1,664		6,224		5,267
Other income (expense)	242		225		755		751
Consolidated profit before taxes	2,558		1,775		6,653		5,642
Provision (benefit) for income taxes	527		368		1,423		1,313
Profit of consolidated companies	2,031		1,407		5,230		4,329
Equity in profit (loss) of unconsolidated affiliated companies	9		21		20		44
Profit of consolidated and affiliated companies	2,040		1,428		5,250		4,373
Less: Profit (loss) attributable to the noncontrolling interests	(1)		2		(1)		4
Profit	$ 2,041	[1]	$ 1,426	[1]	$ 5,251	[2]	$ 4,369	[2]
Profit per common share (in dollars per share)	$ 3.89		$ 2.62		$ 9.91		$ 8.00
Profit per common share - diluted (in dollars per share)	$ 3.87	[3]	$ 2.60	[3]	$ 9.85	[4]	$ 7.94	[4]
Weighted-average common shares outstanding (millions)
Basic (in shares)	525.0		544.0		530.1		545.8
Diluted (in shares)	527.6	[3]	547.6	[3]	533.2	[4]	550.2	[4]
Machinery, Energy & Transportation
Sales and revenues:
Sales and revenues	$ 14,278		$ 11,707		$ 40,703		$ 35,091
Financial Products
Sales and revenues:
Sales and revenues	716		690		2,127		2,082
Operating costs:
Interest expense of Financial Products	151		111		377		352
All other excluding Financial Products
Operating costs:
Interest expense excluding Financial Products	$ 109		$ 114		$ 326		$ 376

[1] Profit attributable to common shareholders.

[2] Profit attributable to common shareholders.

[3] Diluted by assumed exercise of stock-based compensation awards using the treasury stock method.

[4] Diluted by assumed exercise of stock-based compensation awards using the treasury stock method.